@article{cac930e034804ba6b94c8bee5405a4cf,
title = "Cyclosporine for Ocular Inflammatory Diseases",
author = "Ka{\c c}maz, \{R. Oktay\} and Kempen, \{John H.\} and Craig Newcomb and Ebenezer Daniel and Ebenezer Daniel and Sapna Gangaputra and Sapna Gangaputra and Nussenblatt, \{Robert B.\} and Rosenbaum, \{James T.\} and Suhler, \{Eric B.\} and Thorne, \{Jennifer E.\} and Jabs, \{Douglas A.\} and Jabs, \{Douglas A.\} and Levy-Clarke, \{Grace A.\} and Foster, \{C. Stephen\}",
note = "Retrospective cohort study Cyclosporine (Cyclosporine A) is the most commonly used agent in the T-cell inhibitor class of immunosuppressive drugs., Cyclosporine A preferentially inhibits antigen-triggered signal transduction in T lymphocytes, blunting the expression of many lymphokines-including interleukin-2 (IL-2)-and the expression of antiapoptotic proteins.",
year = "2010",
month = mar,
day = "1",
doi = "10.1016/J.OPHTHA.2009.08.010",
language = "American English",
volume = "117",
journal = "Ophthalmology",
number = "3",
}